(OSIS) OSI Systems - NASDAQ
Sector: Technology | Industry: Electronic Components | Exchange: NASDAQ (USA) | Market Cap: 3.717m USD | Total Return: -3.2% in 12m
Avg Turnover: 57.3M
EPS Trend: 93.3%
Qual. Beats: 0
Rev. Trend: 94.4%
Qual. Beats: 0
Warnings
Fakeout Choppy Below Avwap Earnings
Tailwinds
No distinct edge detected
OSI Systems, Inc. (OSIS) is a vertically integrated designer and manufacturer of specialized electronic systems and components. The company operates across three primary segments: Security, Healthcare, and Optoelectronics and Manufacturing. Its Security division, operating under the Rapiscan and S2 brands, provides inspection and screening technologies for aviation, borders, and high-security facilities. This sector is characterized by high barriers to entry due to stringent government certifications and long-term service contracts.
The Healthcare segment focuses on patient monitoring and cardiology systems through the Spacelabs brand, while the Optoelectronics division supplies specialized components like flex circuits and laser diodes to aerospace, defense, and telecommunications markets. By maintaining internal manufacturing capabilities, OSIS controls the production of critical sensors used within its own proprietary security and medical devices. Investors can find further data on OSIS and its industry peers at ValueRay.
Headquartered in Hawthorne, California, the company has operated since 1987, diversifying its revenue streams between government-funded security infrastructure and private-sector medical and industrial equipment. This multi-segment model allows the firm to leverage its core sensor expertise across various regulatory environments and global markets.
- Global airport security modernization cycles drive Rapiscan system replacement revenue
- Large-scale turnkey cargo screening contracts expand long-term service segment margins
- Hospital capital expenditure trends dictate Spacelabs patient monitoring equipment demand
- Aerospace and defense sector growth fuels optoelectronics and manufacturing segment backlog
- Geopolitical instability increases government spending on border and checkpoint security infrastructure
| Net Income: 152.2m TTM > 0 and > 6% of Revenue |
| FCF/TA: 0.03 > 0.02 and ΔFCF/TA 0.78 > 1.0 |
| NWC/Revenue: 65.76% < 20% (prev 39.58%; Δ 26.17% < -1%) |
| CFO/TA 0.04 > 3% & CFO 94.4m > Net Income 152.2m |
| Net Debt (657.3m) to EBITDA (258.9m): 2.54 < 3 |
| Current Ratio: 3.25 > 1.5 & < 3 |
| Outstanding Shares: last quarter (17.4m) vs 12m ago 1.49% < -2% |
| Gross Margin: 32.31% > 18% (prev 33.94%; Δ -1.63% > 0.5%) |
| Asset Turnover: 77.96% > 50% (prev 81.17%; Δ -3.21% > 0%) |
| Interest Coverage Ratio: 7.34 > 6 (EBIT TTM 218.6m / Interest Expense TTM 29.8m) |
| A: 0.47 (Total Current Assets 1.72b - Total Current Liabilities 529.2m) / Total Assets 2.55b |
| B: 0.35 (Retained Earnings 902.2m / Total Assets 2.55b) |
| C: 0.09 (EBIT TTM 218.6m / Avg Total Assets 2.32b) |
| D: 0.54 (Book Value of Equity 894.3m / Total Liabilities 1.66b) |
| Altman-Z'' = 5.40 = AAA |
| DSRI: 1.21 (Receivables 870.5m/672.2m, Revenue 1.81b/1.69b) |
| GMI: 1.05 (GM 33.94% / 32.31%) |
| AQI: 0.85 (AQ_t 0.28 / AQ_t-1 0.33) |
| SGI: 1.07 (Revenue 1.81b / 1.69b) |
| TATA: 0.02 (NI 152.2m - CFO 94.4m) / TA 2.55b) |
| Beneish M = -2.85 (Cap -4..+1) = A |
As of June 19, 2026, the stock is trading at USD 222.78 with a total of 286,128 shares traded.
Over the past week, the price has changed by -0.21%,
over one month by +4.69%,
over three months by -19.17% and
over the past year by -3.23%.
OSI Systems has received a consensus analysts rating of 4.43. Therefore, it is recommended to buy OSIS.
- StrongBuy: 4
- Buy: 2
- Hold: 1
- Sell: 0
- StrongSell: 0
| Analysts Target Price | 300.3 | 34.8% |
P/E Trailing = 25.7749
P/E Forward = 19.685
P/S = 2.0573
P/B = 4.1567
P/EG = 1.6393
Revenue TTM = 1.81b USD
EBIT TTM = 218.6m USD
EBITDA TTM = 258.9m USD
Long Term Debt = 998.7m USD (from longTermDebt, last quarter)
Short Term Debt = 3.79m USD (from shortTermDebt, last quarter)
Debt = 1.00b USD (corrected: LT Debt 998.7m + ST Debt 3.79m)
Net Debt = 657.3m USD (calculated: Debt 1.00b - CCE 345.2m)
Enterprise Value = 4.37b USD (3.72b + Debt 1.00b - CCE 345.2m)
Interest Coverage Ratio = 7.34 (Ebit TTM 218.6m / Interest Expense TTM 29.8m)
EV/FCF = 57.16x (Enterprise Value 4.37b / FCF TTM 76.5m)
FCF Yield = 1.75% (FCF TTM 76.5m / Enterprise Value 4.37b)
FCF Margin = 4.24% (FCF TTM 76.5m / Revenue TTM 1.81b)
Net Margin = 8.42% (Net Income TTM 152.2m / Revenue TTM 1.81b)
Gross Margin = 32.31% ((Revenue TTM 1.81b - Cost of Revenue TTM 1.22b) / Revenue TTM)
Gross Margin QoQ = 31.07% (prev 32.67%)
Tobins Q-Ratio = 1.71 (Enterprise Value 4.37b / Total Assets 2.55b)
Interest Expense / Debt = 2.97% (Interest Expense 29.8m / Debt 1.00b)
Taxrate = 19.36% (36.6m / 188.8m)
NOPAT = 176.2m (EBIT 218.6m * (1 - 19.36%))
Current Ratio = 3.25 (Total Current Assets 1.72b / Total Current Liabilities 529.2m)
Debt / Equity = 1.12 (Debt 1.00b / totalStockholderEquity, last quarter 894.3m)
Debt / EBITDA = 2.54 (Net Debt 657.3m / EBITDA 258.9m)
Debt / FCF = 8.59 (Net Debt 657.3m / FCF TTM 76.5m)
Total Stockholder Equity = 909.2m (last 4 quarters mean from totalStockholderEquity)
RoA = 6.57% (Net Income 152.2m / Total Assets 2.55b)
RoE = 16.74% (Net Income TTM 152.2m / Total Stockholder Equity 909.2m)
RoCE = 11.46% (EBIT 218.6m / Capital Employed (Equity 909.2m + L.T.Debt 998.7m))
RoIC = 9.09% (NOPAT 176.2m / Invested Capital 1.94b)
WACC = 8.27% (E(3.72b)/V(4.72b) * Re(9.85%) + D(1.00b)/V(4.72b) * Rd(2.97%) * (1-Tc(0.19)))
Discount Rate = 9.85% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 15.56 | Cagr: 0.29%
[DCF] Terminal Value 77.97% ; FCFF base≈64.4m ; Y1≈73.8m ; Y5≈108.6m
[DCF] Fair Price = 59.26 (EV 1.63b - Net Debt 657.3m = Equity 976.8m / Shares 16.5m; r=8.35% [WACC [floored]]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 93.27 | EPS CAGR: 17.07% | SUE: 0.69 | # QB: 0
Revenue Correlation: 94.43 | Revenue CAGR: 13.06% | SUE: 0.15 | # QB: 0
EPS next Quarter (2026-09-30): EPS=1.55 | Chg30d=+2.79% | Revisions=+20% | Analysts=4
EPS current Year (2026-06-30): EPS=10.42 | Chg30d=+0.03% | Revisions=-25% | GrowthEPS=+11.3% | GrowthRev=+7.0%
EPS next Year (2027-06-30): EPS=11.41 | Chg30d=-0.34% | Revisions=-25% | GrowthEPS=+9.5% | GrowthRev=+6.0%
[Analyst] Revisions Ratio: -25%